Abstract
In Vitro Evaluation of [18F]Canagliflozin, a Potential PET Tracer for Imaging Tissue Distribution of the SGLT2 Inhibitor Canagliflozin in Type 2 Diabetes Patients In Vivo
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
